Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • March4NETs
NET Nurse
Donate

Home » News » ANZSNM Annual Scientific Meeting 21-23 May 2021

ANZSNM Annual Scientific Meeting 21-23 May 2021

  • May 21, 2021

“Unlocking the Potential of Nuclear Medicine” ANZSNM Annual Scientific Meeting 21 – 23 May 2021

This conference was a hybrid event with face-to-face sites in each state in Australia and virtual presentations, including International guest speakers. Simone and Meredith submitted a Poster – “Survey of Challenges in Access to Diagnostics and Treatment for Neuroendocrine Tumour (NET) Patients (SCAN) –Australia and New Zealand (Oceania) vs Global Diagnosis of NETs”.

This was accepted, with Meredith presenting an e-presentation overview of the SCAN Oceania Data. SCAN, a survey conducted by the International Neuroendocrine Cancer Alliance (INCA) looked at access across the board to different treatments, diagnostics and also issues with early diagnosis. We are heartened to see that access in Australia to vital Nuclear Medicine including PET scans and PRRT is high and so too is the experience of our specialists. 

Meredith attended (in person) the conference at Rydges World Square Sydney. The day commenced with the CEO, Shaun Jenkinson, of the Australian Nuclear Science and Technology Organisation (ANSTO) updating the audience about ANSTO activities, quality processes and improvements and future directions in supply and development. It was a wonderful opportunity to network and work together.

Other highlights of the conference included:

“Experience with COVID-19 in UK”, Prof John Buscombe, British Nuclear Medicine Society, UK

This was a really interesting presentation explaining the management of COVID in the UK and the utilisation of staff, PPE and also the importance of Australian Health Care Professionals in the UK which was of enormous benefit to the UK hospitals staffing. Australians could not leave due to closed borders in Australia and so their work visas were extended and enabled adequate levels of staff to be available.

On day 2 Plenary 1 was Droplet Radiochemistry: new approaches for efficient radiopharmaceutical development and production by Prof Michael van Dam from University of California, Los Angeles. This highlighted the development of equipment to enable de-centralised production – the scale of the equipment is smaller than a regular takeaway coffee cup!

Other sessions were Breast Cancer Imaging modalities, Infection and Inflammation which was a Technologist Syposium and included the impact of COVID on universities and training and also administration of local anaesthetic for sentinel lymphoscintigraphy which significantly reduces pain without reducing detection of lymph nodes.

Click below for the INCA SCAN – Oceania V Global poster and view Merediths overview below.

https://neuroendocrine.org.au/wp-content/uploads/2021/05/poster-mover.mp4
Click here for poster

Share this post

Recent posts

Radio National Interview: Changing Australia June 2025

June 30, 2025

Adelaide NET Patient Forum 2025

June 24, 2025

CNSA & ICCN 2025 Congress: Global Voices, Local Actions

June 24, 2025

Announcing our First Patient Ambassador – Cassie Miller

June 17, 2025
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousBioPharmaDispatch 2021
NextPatient perspectives, from diagnosis through treatments and beyond.Next

Related Posts

Announcing our First Patient Ambassador – Cassie Miller

NeuroEndocrine Cancer Australia is proud to welcome Cassie Miller from Queensland as our very first official Patient Ambassador. Cassie was 36 when she was diagnosed

2025 Impact Report

This year, NeuroEndocrine Cancer Australia continued to expand our reach and impact thanks to the incredible support of our community. Click below to read the

Be the Voice for NET Patients in WA – Join Our CAG Team

Call out for a consumer advisory representative from Western Australia (voluntary position) Are you from Western Australia? Have you experienced a diagnosis of a Neuroendocrine

BioPharmaDispatch 2025: Putting NETs on the National Agenda

BioPharmaDispatch 2025: Putting NETs on the National Agenda NeuroEndocrine Cancer Australia was proud to attend the BioPharmaDispatch 2025 Conference in Sydney this month, represented by

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin